$1.19
At close: Apr 22 EDT
$1.17
-0.02-1.68%
Pre-Market: 7:13 PM EDT
Comments
Loading...
Marker Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:MRKR | Benzinga
Marker Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS Estimate
$-0.320
Quarterly Revenue Estimate
$1.00M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$6.59M
Analyze the earnings history of Marker Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics | -$0.27 | -$0.32 | — | — | $1.24M | $1.00M | — | — | 05/14/2025 | Get Alert |
| MRKR | Marker Therapeutics | -$0.30 | -$0.28 | -$0.42 | -50.00% | $1.06M | $1.00M | $2.25M | 125.20% | 03/31/2025 | Get Alert |
| MRKR | Marker Therapeutics | -$0.34 | -$0.39 | -$0.26 | 33.33% | $257.61K | $1.00M | $1.93M | 92.60% | 11/14/2024 | Get Alert |
| MRKR | Marker Therapeutics | -$0.47 | -$0.43 | -$0.25 | 41.86% | $762.66K | — | $1.17M | — | 08/14/2024 | Get Alert |
| MRKR | Marker Therapeutics | -$0.57 | — | -$0.27 | — | $1.23M | — | $1.24M | — | 05/15/2024 | Get Alert |
| MRKR | Marker Therapeutics | -$0.45 | — | -$0.30 | — | $3.31M | — | $1.06M | — | 03/26/2024 | Get Alert |
| MRKR | Marker Therapeutics | -$0.80 | — | -$0.34 | — | $3.95M | — | $257.61K | — | 11/09/2023 | Get Alert |
| MRKR | Marker Therapeutics | -$1.10 | — | -$0.47 | — | $790.51K | — | $762.66K | — | 08/14/2023 | Get Alert |
| MRKR | Marker Therapeutics | -$1.20 | -$0.80 | -$0.57 | 28.75% | $964.32K | — | $4.73M | — | 05/15/2023 | Get Alert |
| MRKR | Marker Therapeutics | -$1.00 | -$1.60 | -$0.45 | 71.88% | $0.00 | — | $3.31M | — | 03/22/2023 | Get Alert |
| MRKR | Marker Therapeutics | -$1.50 | -$1.20 | -$0.80 | 33.33% | $0.00 | $270.00K | $3.95M | 1362.96% | 11/10/2022 | Get Alert |
| MRKR | Marker Therapeutics | -$1.30 | -$1.30 | -$1.10 | 15.38% | $0.00 | $670.00K | $790.51K | 17.99% | 08/11/2022 | Get Alert |
| MRKR | Marker Therapeutics | -$1.60 | — | -$1.20 | — | $0.00 | — | $964.32K | — | 05/13/2022 | Get Alert |
| MRKR | Marker Therapeutics | -$1.80 | -$1.30 | -$1.20 | 7.69% | $0.00 | — | $0.00 | — | 03/17/2022 | Get Alert |
| MRKR | Marker Therapeutics | -$1.60 | -$1.30 | -$1.20 | 7.69% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| MRKR | Marker Therapeutics | -$1.40 | -$1.20 | -$1.30 | -8.33% | $466.79K | — | $0.00 | — | 08/10/2021 | Get Alert |
| MRKR | Marker Therapeutics | -$1.40 | -$1.40 | -$1.60 | -14.29% | $0.00 | — | $0.00 | — | 05/12/2021 | Get Alert |
| MRKR | Marker Therapeutics | -$1.10 | — | -$1.80 | — | $213.19K | — | $0.00 | — | 03/09/2021 | Get Alert |
| MRKR | Marker Therapeutics | -$1.20 | -$1.40 | -$1.60 | -14.29% | $0.00 | — | $0.00 | — | 11/09/2020 | Get Alert |
| MRKR | Marker Therapeutics | -$1.20 | — | -$1.40 | — | — | — | $466.79K | — | 08/10/2020 | Get Alert |
| MRKR | Marker Therapeutics | — | -$1.10 | -$1.40 | -27.27% | — | — | $0.00 | — | 05/11/2020 | Get Alert |
Marker Therapeutics (MRKR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-31 | $-0.42 | $-0.28 | -50.0 % |
| Q3 | 2024-11-14 | $-0.26 | $-0.39 | 33.3 % |
| Q2 | 2024-08-14 | $-0.25 | $-0.43 | 41.9 % |
| Q1 | 2023-05-15 | $-0.57 | $-0.80 | 28.7 % |
Marker Therapeutics (MRKR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-31 | $2.25M | $1.00M | 125.2 % |
| Q3 | 2024-11-14 | $1.93M | $1.00M | 92.6 % |
| Q3 | 2022-11-10 | $3.95M | $270.00K | 1363.0 % |
| Q2 | 2022-08-11 | $790.51K | $670.00K | 18.0 % |
FAQ
When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?
Marker Therapeutics (MRKR) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on March 31, 2025 for Q4.
What were the latest earnings per share (EPS) for Marker Therapeutics (NASDAQ:MRKR)?
The Actual EPS was $-0.42, which missed the estimate of $-0.28.
What were Marker Therapeutics’s (NASDAQ:MRKR) revenues?
The Actual Revenue was $2.3M, which beat the estimate of $1M.
Browse earnings estimates, EPS, and revenue on all stocks.
